Cookie Consent by Free Privacy Policy Generator
Search
Close this search box.

Qu&Co, Janssen Pharmaceuticals to Develop and Test Quantum Computational Methods Pharma R&D

Qu&Co
Qu&Co
Qu&Co and Janssen Pharmaceuticals are exploring ways that pharmaceutical researchers can use quantum technology in research and development.

Qu&Co, a European quantum computational software developer and Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, are launching a three-year research collaboration to develop and test novel quantum computational algorithms and software for applications in pharmaceutical research and development, according to a statement from the companies.

Computational chemistry and machine learning techniques have become powerful tools to accelerate pharmaceutical R&D and quantum computing, in-time, promises to bring further enhancements of such techniques and tools. This collaboration with Qu&Co will determine how pharmaceutical R&D could benefit from quantum computing and on what timeframe one could expect to see the earliest benefits.

Vincent Elfving, CTO at Qu&Co, said “Collaborations with deep domain experts in computational chemistry are key for us to understand where the conventional best-in-class computational techniques are struggling, so that we focus our research on those areas where there is a potential promise of industry relevant quantum advantage”

The collaboration will focus on developing quantum computational solutions and testing them on quantum processors. Part of the research will also employ ‘QUBEC’, Qu&Co’s platform for quantum computational chemistry and materials-science, which offers corporate researchers a glimpse of what the future of computational chemistry will look like.

About Qu & Co
Qu&Co is a quantum computational software company founded in 2017 in Amsterdam, the Netherlands. Its software will empower corporate researchers to run complex chemistry and multiphysics simulations on future quantum processors with unprecedented accuracy and speed. Qu&Co’s SaaS quantum solutions, like its chemistry and materials-science platform ‘QUBEC’, include unique and patented quantum algorithms and are distributed as backend integrations to leading conventional software packages. Qu&Co clients include corporate researchers from a range of large multinationals, and it has partnerships with US and European quantum hardware players and R&D collaborations with leading Universities from around the world. For more information visit www.quandco.com.

Responsive Image

About Janssen Pharmaceuticals
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at www.janssen.com.

For more market insights, check out our latest quantum computing news here.

The Future of Materials Discovery: Reducing R&D Costs significantly with GenMat’s AI and Machine Learning Tools

When: July 13, 2023 at 11:30am

What: GenMat Webinar

Picture of Jake Vikoren

Jake Vikoren

Company Speaker

Picture of Deep Prasad

Deep Prasad

Company Speaker

Picture of Araceli Venegas

Araceli Venegas

Company Speaker

Matt Swayne

With a several-decades long background in journalism and communications, Matt Swayne has worked as a science communicator for an R1 university for more than 12 years, specializing in translating high tech and deep tech for the general audience. He has served as a writer, editor and analyst at The Quantum Insider since its inception. In addition to his service as a science communicator, Matt also develops courses to improve the media and communications skills of scientists and has taught courses. [email protected]

Share this article:

Relevant

The Future of Materials Discovery: Reducing R&D Costs significantly with GenMat’s AI and Machine Learning Tools

When: July 13, 2023 at 11:30am

What: GenMat Webinar

Picture of Jake Vikoren

Jake Vikoren

Company Speaker

Picture of Deep Prasad

Deep Prasad

Company Speaker

Picture of Araceli Venegas

Araceli Venegas

Company Speaker

Keep track of everything going on in the Quantum Technology Market.

In one place.

Join Our Newsletter